메뉴 건너뛰기




Volumn 35, Issue 6, 2011, Pages 757-761

Pre-transplant consolidation chemotherapy may not improve outcomes after reduced intensity conditioning hematopoietic stem cell transplantation for acute myeloid leukemia in first complete remission

Author keywords

Allogeneic stem cell transplantation; AML; Consolidation therapy; CR1; Reduced intensity conditioning

Indexed keywords

CYCLOPHOSPHAMIDE; CYTARABINE; ETOPOSIDE; FLUDARABINE; GRANULOCYTE COLONY STIMULATING FACTOR; IDARUBICIN; MITOXANTRONE; THYMOCYTE ANTIBODY;

EID: 79955634448     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.leukres.2010.12.013     Document Type: Article
Times cited : (12)

References (19)
  • 1
    • 0028889993 scopus 로고
    • Autologous or allogeneic bone marrow transplantation compared with intensive chemotherapy in acute myelogenous leukemia. European Organization for Research and Treatment of Cancer (EORTC) and the Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto (GIMEMA) Leukemia Cooperative Groups
    • Zittoun R.A., Mandelli F., Willemze R., de Witte T., Labar B., Resegotti L., et al. Autologous or allogeneic bone marrow transplantation compared with intensive chemotherapy in acute myelogenous leukemia. European Organization for Research and Treatment of Cancer (EORTC) and the Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto (GIMEMA) Leukemia Cooperative Groups. N Engl J Med 1995, 332:217-223.
    • (1995) N Engl J Med , vol.332 , pp. 217-223
    • Zittoun, R.A.1    Mandelli, F.2    Willemze, R.3    de Witte, T.4    Labar, B.5    Resegotti, L.6
  • 2
    • 67049164836 scopus 로고    scopus 로고
    • Allogeneic stem cell transplantation for acute myeloid leukemia in first complete remission: systematic review and meta-analysis of prospective clinical trials
    • Koreth J., Schlenk R., Kopecky K.J., Honda S., Sierra J., Djulbegovic B.J., et al. Allogeneic stem cell transplantation for acute myeloid leukemia in first complete remission: systematic review and meta-analysis of prospective clinical trials. JAMA 2009, 301:2349-2361.
    • (2009) JAMA , vol.301 , pp. 2349-2361
    • Koreth, J.1    Schlenk, R.2    Kopecky, K.J.3    Honda, S.4    Sierra, J.5    Djulbegovic, B.J.6
  • 3
    • 13544257121 scopus 로고    scopus 로고
    • Comparative outcome of nonmyeloablative and myeloablative allogeneic hematopoietic cell transplantation for patients older than 50 years of age
    • Alyea E.P., Kim H.T., Ho V., Cutler C., Gribben J., DeAngelo D.J., et al. Comparative outcome of nonmyeloablative and myeloablative allogeneic hematopoietic cell transplantation for patients older than 50 years of age. Blood 2005, 105:1810-1814.
    • (2005) Blood , vol.105 , pp. 1810-1814
    • Alyea, E.P.1    Kim, H.T.2    Ho, V.3    Cutler, C.4    Gribben, J.5    DeAngelo, D.J.6
  • 4
    • 38949190551 scopus 로고    scopus 로고
    • Reduced-intensity allogeneic transplant in patients older than 55 years: unrelated umbilical cord blood is safe and effective for patients without a matched related donor
    • Majhail N.S., Brunstein C.G., Tomblyn M., Thomas A.J., Miller J.S., Arora M., et al. Reduced-intensity allogeneic transplant in patients older than 55 years: unrelated umbilical cord blood is safe and effective for patients without a matched related donor. Biol Blood Marrow Transplant 2008, 14:282-289.
    • (2008) Biol Blood Marrow Transplant , vol.14 , pp. 282-289
    • Majhail, N.S.1    Brunstein, C.G.2    Tomblyn, M.3    Thomas, A.J.4    Miller, J.S.5    Arora, M.6
  • 5
    • 73249115577 scopus 로고    scopus 로고
    • Similar outcomes using myeloablative versus reduced intensity and non-myeloablative allogeneic transplant preparative regimens for AML or MDS: from the center for international blood and marrow transplant research
    • [Abstract 348]
    • Luger S., Ringden O., Perez W.S., Zhang M.-J., DiPersio J.F., Sierra J., et al. Similar outcomes using myeloablative versus reduced intensity and non-myeloablative allogeneic transplant preparative regimens for AML or MDS: from the center for international blood and marrow transplant research. Blood 2008, 112. [Abstract 348].
    • (2008) Blood , vol.112
    • Luger, S.1    Ringden, O.2    Perez, W.S.3    Zhang, M.-J.4    DiPersio, J.F.5    Sierra, J.6
  • 6
    • 34848855770 scopus 로고    scopus 로고
    • Reduced intensity compared with high dose conditioning for allotransplantation in acute myeloid leukemia and myelodysplastic syndrome: a comparative clinical analysis
    • Flynn C.M., Hirsch B., Defor T., Barker J.N., Miller J.S., Wagner J.E., et al. Reduced intensity compared with high dose conditioning for allotransplantation in acute myeloid leukemia and myelodysplastic syndrome: a comparative clinical analysis. Am J Hematol 2007, 82:867-872.
    • (2007) Am J Hematol , vol.82 , pp. 867-872
    • Flynn, C.M.1    Hirsch, B.2    Defor, T.3    Barker, J.N.4    Miller, J.S.5    Wagner, J.E.6
  • 7
    • 33750205692 scopus 로고    scopus 로고
    • Impact of conditioning regimen intensity on outcome of allogeneic hematopoietic cell transplantation for advanced acute myelogenous leukemia and myelodysplastic syndrome
    • Alyea E.P., Kim H.T., Ho V., Cutler C., DeAngelo D.J., Stone R., et al. Impact of conditioning regimen intensity on outcome of allogeneic hematopoietic cell transplantation for advanced acute myelogenous leukemia and myelodysplastic syndrome. Biol Blood Marrow Transplant 2006, 12:1047-1055.
    • (2006) Biol Blood Marrow Transplant , vol.12 , pp. 1047-1055
    • Alyea, E.P.1    Kim, H.T.2    Ho, V.3    Cutler, C.4    DeAngelo, D.J.5    Stone, R.6
  • 8
    • 33746661102 scopus 로고    scopus 로고
    • Retrospective comparison of reduced-intensity conditioning and conventional high-dose conditioning for allogeneic hematopoietic stem cell transplantation using HLA-identical sibling donors in myelodysplastic syndromes
    • Martino R., Iacobelli S., Brand R., Jansen T., van Biezen A., Finke J., et al. Retrospective comparison of reduced-intensity conditioning and conventional high-dose conditioning for allogeneic hematopoietic stem cell transplantation using HLA-identical sibling donors in myelodysplastic syndromes. Blood 2006, 108:836-846.
    • (2006) Blood , vol.108 , pp. 836-846
    • Martino, R.1    Iacobelli, S.2    Brand, R.3    Jansen, T.4    van Biezen, A.5    Finke, J.6
  • 9
    • 38349195008 scopus 로고    scopus 로고
    • Comparable non-relapse mortality and survival after HLA-identical sibling blood stem cell transplantation with reduced or conventional-intensity preparative regimens for high-risk myelodysplasia or acute myeloid leukemia in first remission
    • Martino R., Valcarcel D., Brunet S., Sureda A., Sierra J. Comparable non-relapse mortality and survival after HLA-identical sibling blood stem cell transplantation with reduced or conventional-intensity preparative regimens for high-risk myelodysplasia or acute myeloid leukemia in first remission. Bone Marrow Transplant 2008, 41:33-38.
    • (2008) Bone Marrow Transplant , vol.41 , pp. 33-38
    • Martino, R.1    Valcarcel, D.2    Brunet, S.3    Sureda, A.4    Sierra, J.5
  • 10
    • 0027941369 scopus 로고
    • Intensive postremission chemotherapy in adults with acute myeloid leukemia. Cancer and Leukemia Group B
    • Mayer R.J., Davis R.B., Schiffer C.A., Berg D.T., Powell B.L., Schulman P., et al. Intensive postremission chemotherapy in adults with acute myeloid leukemia. Cancer and Leukemia Group B. N Engl J Med 1994, 331:896-903.
    • (1994) N Engl J Med , vol.331 , pp. 896-903
    • Mayer, R.J.1    Davis, R.B.2    Schiffer, C.A.3    Berg, D.T.4    Powell, B.L.5    Schulman, P.6
  • 11
    • 0034663034 scopus 로고    scopus 로고
    • Effect of postremission chemotherapy before human leukocyte antigen-identical sibling transplantation for acute myelogenous leukemia in first complete remission
    • Tallman M.S., Rowlings P.A., Milone G., Zhang M.J., Perez W.S., Weisdorf D., et al. Effect of postremission chemotherapy before human leukocyte antigen-identical sibling transplantation for acute myelogenous leukemia in first complete remission. Blood 2000, 96:1254-1258.
    • (2000) Blood , vol.96 , pp. 1254-1258
    • Tallman, M.S.1    Rowlings, P.A.2    Milone, G.3    Zhang, M.J.4    Perez, W.S.5    Weisdorf, D.6
  • 12
    • 31344460389 scopus 로고    scopus 로고
    • Pretransplantation consolidation chemotherapy decreases leukemia relapse after autologous blood and bone marrow transplants for acute myelogenous leukemia in first remission
    • Tallman M.S., Perez W.S., Lazarus H.M., Gale R.P., Maziarz R.T., Rowe J.M., et al. Pretransplantation consolidation chemotherapy decreases leukemia relapse after autologous blood and bone marrow transplants for acute myelogenous leukemia in first remission. Biol Blood Marrow Transplant 2006, 12:204-216.
    • (2006) Biol Blood Marrow Transplant , vol.12 , pp. 204-216
    • Tallman, M.S.1    Perez, W.S.2    Lazarus, H.M.3    Gale, R.P.4    Maziarz, R.T.5    Rowe, J.M.6
  • 13
    • 70349256226 scopus 로고    scopus 로고
    • The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes
    • Vardiman J.W., Thiele J., Arber D.A., Brunning R.D., Borowitz M.J., Porwit A., et al. The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes. Blood 2009, 114:937-951.
    • (2009) Blood , vol.114 , pp. 937-951
    • Vardiman, J.W.1    Thiele, J.2    Arber, D.A.3    Brunning, R.D.4    Borowitz, M.J.5    Porwit, A.6
  • 14
    • 0037114753 scopus 로고    scopus 로고
    • Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B (CALGB 8461)
    • Byrd J.C., Mrozek K., Dodge R.K., Carroll A.J., Edwards C.G., Arthur D.C., et al. Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B (CALGB 8461). Blood 2002, 100:4325-4336.
    • (2002) Blood , vol.100 , pp. 4325-4336
    • Byrd, J.C.1    Mrozek, K.2    Dodge, R.K.3    Carroll, A.J.4    Edwards, C.G.5    Arthur, D.C.6
  • 15
    • 23944440464 scopus 로고    scopus 로고
    • Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT
    • Sorror M.L., Maris M.B., Storb R., Baron F., Sandmaier B.M., Maloney D.G., et al. Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT. Blood 2005, 106:2912-2919.
    • (2005) Blood , vol.106 , pp. 2912-2919
    • Sorror, M.L.1    Maris, M.B.2    Storb, R.3    Baron, F.4    Sandmaier, B.M.5    Maloney, D.G.6
  • 16
    • 33845382806 scopus 로고
    • Nonparametric estimation from incomplete observations
    • Kaplan E.L., Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958, 53:457-481.
    • (1958) J Am Stat Assoc , vol.53 , pp. 457-481
    • Kaplan, E.L.1    Meier, P.2
  • 17
    • 0000336139 scopus 로고
    • Regression models and life-tables
    • Cox D.R. Regression models and life-tables. J R Stat Soc B - Methodological 1972, 34:187-220.
    • (1972) J R Stat Soc B - Methodological , vol.34 , pp. 187-220
    • Cox, D.R.1
  • 18
    • 1542532754 scopus 로고    scopus 로고
    • A proportional hazards model for the subdistribution of a competing risk
    • Jason P.F., Gray R.J. A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc 1999, 94:496-509.
    • (1999) J Am Stat Assoc , vol.94 , pp. 496-509
    • Jason, P.F.1    Gray, R.J.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.